Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Immunological and Vascular Effects of Aspirin in Prevention of Preeclampsia in High-risk Nulliparous Women

NCT06200571 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT06200571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06200571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Immunological and Vascular Effects of Aspirin in Prevention of Preeclampsia in High-risk Nulliparous Women
Lead sponsor
Norwegian University of Science and Technology
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 22, 2024
Completion date
December 31, 2032
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia